Atlas Trials

Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma

Clinical trial NCT06468605 · WITHDRAWN

Trial details

NCT number
NCT06468605
Sponsor
Duke University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent or Progressive High-grade Glioma
Start date
2025-11-01
Primary completion
2027-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.